A stable nanoplatform for antitumor activity using PEG-PLL-PLA triblock co-polyelectrolyte

Area of Science:

• Biomaterials Science
• Nanotechnology
• Drug Delivery Systems

Background:

• Conventional polyelectrolytes face challenges in drug delivery due to in vivo dissociation.
• A need exists for stable, self-assembling nanocarriers for effective therapeutic delivery.

Purpose of the Study:

• To develop a stable triblock co-polyelectrolyte nanoplatform for enhanced drug delivery.
• To evaluate the in vitro and in vivo performance of the nanoplatform for anticancer therapy.

Main Methods:

• Synthesis of triblock co-polyelectrolytes (poly(ethylene glycol)-poly(l-lysine)-poly(lactic acid)).
• Characterization of nanoplatform stability, particle size, and drug loading (doxorubicin).
• In vitro cellular uptake and cytotoxicity assays.
• In vivo tumor accumulation and therapeutic efficacy studies.

Main Results:

• The triblock co-polyelectrolytes formed stable aggregates via hydrophobic interactions, maintaining size in high salt concentrations.
• Doxorubicin-loaded nanoplatforms showed increased cellular uptake and cytotoxicity.
• Significant tumor accumulation and potent antitumor efficacy were observed in vivo.

Conclusions:

• The developed stable triblock co-polyelectrolyte nanoplatform demonstrates promise for anticancer drug delivery.
• This nanomedicinal platform may be suitable for combination therapies and advanced drug formulations.